Abstract
Early identification, diagnosis and treatment of TAFRO syndrome are very importants. We retrospectively analysed 6 patients with TAFRO syndrome. Their clinical manifestations, treatment methods, survival and other aspects were summarized. All patients were pathologically diagnosed with Castleman's disease, with fever, an inflammatory storm state and varying degrees of anasarca. All patients received steroid therapy; four of them also received chemotherapy, and 1 received rituximab. Of the 3 patients with severe disease, only 1 patient who received the recommended dose of glucocorticoids survived. Early administration of glucocorticoids can improve the prognosis, especially in patients with severe disease, and adequate glucocorticoids are important.
Full Text
Topics from this Paper
TAFRO Syndrome
Patients Received Steroid Therapy
Castleman's Disease
Severe Disease
Clinical Treatment Methods
+ Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Blood
Dec 2, 2016
World Journal of Clinical Cases
Feb 16, 2022
The Tohoku Journal of Experimental Medicine
Jan 1, 2015
Mar 1, 2021
Kidney Medicine
Mar 1, 2021
International Journal of Hematology
May 31, 2016
Rinsho Ketsueki
Jan 1, 2016
International Journal of Blood Transfusion and Hematology
Mar 20, 2018
Indian Journal of Nephrology
Jan 1, 2022
Medicine
Jun 1, 2018
National Medical Journal of China
Mar 3, 2020
Revista Colombiana de Reumatología
Oct 1, 2022
BMC Nephrology
Nov 23, 2020
Oxford Medical Case Reports
Jun 1, 2017
Annals of hematology
Annals of hematology
Nov 28, 2023
Annals of hematology
Nov 27, 2023
Annals of hematology
Nov 27, 2023
Annals of hematology
Nov 27, 2023
Annals of hematology
Nov 18, 2023
Annals of hematology
Nov 17, 2023
Annals of hematology
Nov 16, 2023
Annals of hematology
Oct 27, 2023
Annals of hematology
Oct 26, 2023
Annals of hematology
Oct 26, 2023